Swipe om te navigeren naar een ander artikel
Previous findings regarding depression treatment and its consequences on health-related quality of life (HRQoL) of adults with diabetes were inconsistent and targeted certain groups of population. Therefore, there is a critical need to conduct a population-based study that focuses on a general population with diabetes and depression.
The primary aim of this study was to examine the physical and mental HRQoL associated with depression treatment during the follow-up year.
We adopted a longitudinal design using multiple panels (2005–2011) of the Medical Expenditure Panel Survey to create a baseline year and follow-up year. We included adults with diabetes and depression. We categorized the baseline depression treatment into: (1) antidepressant use only; (2) psychotherapy with or without antidepressants; and (3) no treatment. HRQOL was measured using SF-12 version 2 physical component summary (PCS) and SF-12 mental component summary (MCS) scores during both baseline year and follow-up year. Ordinary least squares (OLS) were used to estimate the association between depression treatment and the HRQoL measures. The OLS regression controlled for predisposing, enabling, need, external environment factors, personal health practices, and baseline HRQoL measures.
After controlling for all the independent variables and the baseline PCS, individuals who received psychotherapy with or without antidepressants had higher PCS scores as compared to those without any treatment for depression (beta = 1.28, p < 0.001). Individuals who reported using only antidepressants had lower PCS scores (beta = −0.54, p < 0.001) as compared to those without depression treatment. On the contrary, individuals who reported receiving psychotherapy with or without antidepressants had lower MCS scores as compared to those without depression treatment (beta = −1.43, p < 0.001). Those using only antidepressants had higher MCS scores as compared to those without depression treatment (beta = 0.56, p < 0.001).
The associations between depression treatment and the HRQoL varied by the type of depression treatment and the component of the HRQoL measures.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Pawaskar, M. D., Anderson, R. T., & Balkrishnan, R. (2007). Self-reported predictors of depressive symptomatology in an elderly population with type 2 diabetes mellitus: A prospective cohort study. Health Quality Life Outcomes, 5, 50. CrossRef
McCollum, M., Ellis, S. L., Regensteiner, J. G., Zhang, W., & Sullivan, P. W. (2007). Minor depression and health status among US adults with diabetes mellitus. The American Journal of Managed Care, 13(2), 65–72. PubMed
Egeden, L., Nietert, P., & Zheng, D. (2005). Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care, 28(6), 1339–1345. CrossRef
Egede, L. E., & Ellis, C. (2010). The effects of depression on metabolic control and quality of life in indigent patients with type 2 diabetes. Diabetes Technology & Therapeutics, 12(4), 257–262. CrossRef
Echeverry, D., Duran, P., Bonds, C., Lee, M., & Davidson, M. B. (2009). Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: A randomized, double-blind, placebo-controlled trial. Diabetes Care, 32(12), 2156–2160. CrossRefPubMedPubMedCentral
Wu, B., Jin, H., Vidyanti, I., Lee, P., Ell, K., & Wu, S. (2014). Collaborative depression care among Latino patients in diabetes disease management, Los Angeles, 2011–2013. Preventing Chronic Disease, 11, 140081. CrossRef
Cohen, S. B., DiGaetano, R., & Goksel, H. (1999). Methodology Report# 5: Estimation procedures in the 1996 MEPS household component.
Smith, M., Davis, M. A., Stano, M., & Whedon, J. M. (2013). Aging baby boomers and the rising cost of chronic back pain: Secular trend analysis of longitudinal Medical Expenditures Panel Survey data for years 2000 to 2007. Journal of Manipulative and Physiological Therapeutics, 36(1), 2–11. CrossRefPubMedPubMedCentral
Medical Expenditure Panel Survey, Household Component. http://meps.ahrq.gov/mepsweb/survey_comp/household.jsp. Accessed 9 March 2014.
Medical Expenditure Panel Survey Clinical Classification Code to ICD-9-CM Code Crosswalk. http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h128/h128_icd9codes.shtml. Accessed 11 March 2014.
Ware, J. E., Kosinski, M., Turner-Bowker, D. M., & Gandek, B. (2002). SF-12v2: how to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Lincoln, RI: QualityMetric Inc.
Moriarty, D. G., Zack, M. M., & Kobau, R. (2003). The Centers for Disease Control and Prevention’s Healthy Days Measures—population tracking of perceived physical and mental health over time. Health and Quality of Life Outcomes, 2(1), 37. CrossRef
Goodnick, P. J., Henry, J. H., & Buki, V. (1995). Treatment of depression in patients with diabetes mellitus. Journal of Clinical Psychiatry, 56(4), 128–136. PubMed
- Depression treatment and health-related quality of life among adults with diabetes and depression
Ebtihag O. Alenzi
- Springer International Publishing